摘要:
Described herein are embodiments of systems and methods for oxidizing gases. In some embodiments, a reaction chamber is configured to receive a fuel gas and maintain the gas at a temperature within the reaction chamber that is above an autoignition temperature of the gas. The reaction chamber may also be configured to maintain a reaction temperature within the reaction chamber below a flameout temperature. In some embodiments, heat and product gases from the oxidation process can be used, for example, to drive a turbine, reciprocating engine, and injected back into the reaction chamber.
摘要:
In various embodiments, methods and compositions for treating Raynaud's disease and Raynaud's phenomenon are provided. Topical administration of a semisolid composition comprising a prostaglandin E1 compound provides the desired relief of the Raynaud's disease or Raynaud's phenomenon without the possible complications of systemic administration. The semisolid composition can be administered as needed, or in a regimen of several doses per day.
摘要:
Compounds, pharmaceutical compositions and methods for modulating the activity of nuclear receptors are provided. In particular, quinazolinones are provided for modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors.
摘要:
The present invention relates to the cosmetic use of a lysate of a bacterium or bacteria belonging to the Vitreoscilla sp. genus (in particular the species: Vitreoscilla filiformis) in a complete fermentation medium, as an active agent for preventing and/or treating dandruff conditions of the scalp, including dandruff conditions of the scalp associated with a prevalence of pathogenic microorganisms on the scalp and/or an imbalance of the scalp ecoflora.
摘要:
The present disclosure includes an adapter and associated method of use for mobile unit (MU) charging and communication that enables multiple connector types to be utilized with a single charger or charging station. The adapter enables standardization of a connector scheme on newer MUs while maintaining compatibility with current or older MU devices. Specifically, the adapter resides between the MU and a charging device or station. The adapter may include various connector features mimicking connectors of various different MUs, thus allowing it to interface with a device of a different connector design. Advantageously, the adapter enables enterprises to deploy various cradles throughout facilities and achieves universal connections for a plurality of different MUs. In an exemplary embodiment, the adapter provides connectivity between various MUs and their associated cradles and a hook and pivoting latching system.
摘要:
Compounds, pharmaceutically acceptable salts, isomers, or prodrugs thereof, of the invention are disclosed, which are useful as modulators of the activity of liver X receptors (LXR). Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
摘要:
A method for communication is disclosed and includes performing by one or more processors in a first access point, receiving a first messaging protocol message from a first switch. The first messaging protocol message is also communicated from the first switch to at least a second switch. A second messaging protocol message may be communicated to the second switch and/or a second access point based on the receiving of the first messaging protocol message. Operation of the first switch, the second switch, the first access point, the second access point, and/or at least one of a plurality of access devices may be controlled utilizing the first messaging protocol message and/or at least the second messaging protocol message. The first messaging protocol message may be generated by the first switch. The first messaging protocol message and the second messaging protocol message may be an access point status message.
摘要:
A compound according to Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R11, L1 and X are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
摘要:
Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.
摘要:
The present invention comprises TGR5 agonists of structural formula I, wherein X, R1, R2, and R5 are defined herein, as well as N-oxides of them and pharmaceutically acceptable salts thereof. The invention further comprises composition comprising the compounds, N-oxides, and/or pharmaceutically acceptable salts thereof. The invention also comprises use of the compounds and compositions for treating diseases in which TGR5 is a mediator or is implicated. The invention also comprises use of the compounds in and for the manufacture of medicaments, particularly for treating diseases in which TGR5 is a mediator or is implicated.